{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:22:23Z","timestamp":1783351343896,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ophtha.2022.02.025","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T18:54:46Z","timestamp":1645901686000},"page":"765-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Punctal Stenosis Associated with Topical Netarsudil Use"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5279-4146","authenticated-orcid":false,"given":"Thomas M.","family":"Meirick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu C.","family":"Mudumbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9558-9492","authenticated-orcid":false,"given":"Philip P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2022.02.025_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2014.08.022","article-title":"Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure","volume":"122","author":"Bacharach","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.02.025_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajo.2019.03.002","article-title":"Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study","volume":"204","author":"Khouri","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)","volume":"200","author":"Kahook","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib5","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/IJG.0000000000001636","article-title":"Reticular epithelial edema: an uncommon side effect of rock\/net inhibitor netarsudil","volume":"29","author":"Chen","year":"2020","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ophtha.2022.02.025_bib6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/ICO.0000000000002621","article-title":"Transient reticular cystic corneal epithelial edema with topical netarsudil: a case series and review","volume":"40","author":"LoBue","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2022.02.025_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ogla.2021.03.014","article-title":"Effectiveness and tolerability of netarsudil in combination with other ocular hypotensive agents","volume":"4","author":"Prager","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2022.02.025_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ogla.2019.03.007","article-title":"Once-daily netarsudil\/latanoprost fixed-dose combination for elevated intraocular pressure in the randomized phase 3 MERCURY-2 study","volume":"2","author":"Walters","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2022.02.025_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/14728222.9.4.715","article-title":"Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges","volume":"9","author":"Hu","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ophtha.2022.02.025_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12886-020-01490-1","article-title":"Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study","volume":"20","author":"Tanihara","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0002-9394(03)00664-0","article-title":"Acquired external punctal stenosis: etiology and associated findings","volume":"136","author":"Kashkouli","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1442-9071.1998.tb01315.x","article-title":"Lacrimal canalicular obstruction associated with topical ocular medication","volume":"26","author":"McNab","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00417-019-04514-9","article-title":"A\u00a0histopathological study of lacrimal puncta in patients with primary punctal stenosis","volume":"258","author":"Jang","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002341-198804040-00006","article-title":"Size variation of the lacrimal punctum in adults","volume":"4","author":"Carter","year":"1988","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2022.02.025_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ajo.2011.07.010","article-title":"Punctal and canalicular anatomy: implications for canalicular occlusion in severe dry eye","volume":"153","author":"Kazizaki","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9394(89)90214-6","article-title":"Punctal occlusion and topical medications for glaucoma","volume":"107","author":"Huang","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.02.025_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0420.1996.tb00720.x","article-title":"The effects of nasolacrimal canal blockage on topical medications for glaucoma","volume":"74","author":"Ariturk","year":"1996","journal-title":"Acta Ophthalmol Scand"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022001646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022001646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:11:38Z","timestamp":1758982298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022001646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0161642022001646"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.025","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Punctal Stenosis Associated with Topical Netarsudil Use","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}